Related Experiment Video
Updated: Aug 12, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Effect of TRIB1 Variant on Lipid Profile and Coronary Artery Disease: A Systematic Review and Meta-Analysis
Baozhu Wei1,2, Yang Liu3, Hang Li4
1Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
Insights
Tribbles homolog 1 (Trib1) gene variants (rs17321515 and rs2954029) are linked to higher cholesterol and coronary artery disease (CAD) risk, particularly in Asian populations.
Area of Science:
- Genetics and Molecular Biology
- Cardiovascular Disease Research
- Metabolic Disorders
Background:
- Tribbles homolog 1 (Trib1) protein's role in lipid metabolism and coronary artery disease (CAD) pathogenesis is under investigation.
- The impact of specific TRIB1 gene variants on lipid profiles and CAD risk requires clarification.
Approach:
- A comprehensive meta-analysis was conducted, including 108,831 individuals from studies published before December 18, 2022.
- PubMed and Cochrane databases were systematically searched to identify relevant research.
Key Points:
- Carriers of the A allele for TRIB1 variants rs17321515 and rs2954029 exhibited elevated levels of low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC).
- A statistically significant association was found between these TRIB1 variants and an increased risk of CAD.
- Subgroup analysis revealed that the observed increases in LDL-C, TC, and CAD risk were particularly pronounced in the Asian population.
Conclusions:
- TRIB1 gene variants, specifically rs17321515 and rs2954029, may function as causal genetic markers for dyslipidemia.
- These TRIB1 variants are potentially significant contributors to CAD pathogenesis, especially within the Asian demographic.
Background:
Emerging evidence indicates tribbles homolog 1 (Trib1) protein may be involved in lipid metabolism regulation and coronary artery disease (CAD) pathogenesis. However, whether TRIB1 gene variants affect lipid levels and CAD remains elusive, this study is aimed at clarifying the effect of TRIB1 variants on lipid profile and CAD.
Methods:
By searching PubMed and Cochrane databases for studies published before December 18, 2022, a total of 108,831 individuals were included for the analysis.
Results:
The outcomes of the analysis on all individuals showed that the A allele carriers of rs17321515 and rs2954029 variants had higher low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) levels than the noncarriers. Consistently, a higher CAD risk was observed in the A allele carriers. Subgroup analysis indicated that increased LDL-C, TC, and CAD risk were observed in Asian population.
Conclusions:
Variants of TRIB1 (i.e., rs17321515 and rs2954029) may serve as causal genetic markers for dyslipidemia and CAD in Asian population.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction
Lipid Catabolism

